October 01, 2014 9:52 PM ET

Healthcare Equipment and Supplies

Company Overview of Datex-Ohmeda, Inc.

Executive Profile

Roger G. Stoll Ph.D.

Executive Chairman, Member of Nominating & Corporate Governance Committee, Member of Compensation & Stock Option Committee and Member of Transition Committee, Delcath Systems, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 10 different industries.

See Board Relationships
71$78,040

Background

Dr. Roger G. Stoll, Ph.D. serves as an Executive Officer of Datex-Ohmeda. Dr. Stoll Co-founded MassHealth Ventures LLP and serves as its Partner. He served as President and Chief Executive Officer of Cortex Pharmaceuticals Inc., from August 13, 2002 to August 13, 2008. He served as an Executive Vice President of Fresenius Medical Care AG & Co. KGaA (formerly, Fresenius Medical Care Holdings Inc.) until January 31, 2001. From 1998 to January 2001, he served as an Executive ...

Corporate Headquarters

3030 Ohmeda Drive
Madison, Wisconsin 53718

United States

Phone: 608-221-1551
Fax: 608-221-9147

Board Members Memberships

Director
Former Executive Vice President and Director
1998-N/A
Former Director
1999-N/A
Former Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2002-2012
Former Executive Chairman
2002-2003
Former Director
2008-Present
Executive Chairman, Member of Nominating & Corporate Governance Committee, Member of Compensation & Stock Option Committee and Member of Transition Committee
2008-Present
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit & Risk Management Committee, Member of Strategic Advisory Committee and Member of Compensation Committee

Education

Post-Doctoral Training
University of Michigan
PhD
University of Connecticut
BS
Ferris State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$65,500
Total Calculated Compensation$78,040
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$738.5K
Gilman E. Wong Chief Executive Officer, Managing Director and Executive Director
Sirtex Medical Limited
$998.5K
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$871.4K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Datex-Ohmeda, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.